Laballensaeure | 16863-62-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Laballensaeure
• 英文别名: 5,6-Octadecadienoic acid
• CAS: 16863-62-0
• 化学式: C₁₈H₃₂O₂
• 分子量: 280.451
• InChiKey: YXJXBVWHSBEPDQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  20
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  甲醇 、 Laballensaeure 在 盐酸 作用下， 生成 (+/-)-Laballensaeuremethylester
  参考文献：
  名称：

  艾伦。第二十二部分。戊二烯酸和Lamenallenic酸的合成和绝对构型

  摘要：

  描述了两种天然存在的烯丙酸（​​–）-octadeca-5,6-dinoic acid（laballenic acid）（-）-octa-deca-5,6- trans -16-trienoic acid（lamenallenic acid）的合成，两者都显示出具有的[R构型

  DOI：

  10.1039/p19720002197
• 作为产物：
  描述：

  hexadec-2-en-4-yn-1-ol 在 lithium aluminium tetrahydride 作用下， 生成 Laballensaeure
  参考文献：
  名称：

  The synthesis and absolute configuration of laballenic acid

  摘要：

  DOI：

  10.1016/s0040-4039(00)70112-2

文献信息

• [EN] MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OF REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS<br/>[FR] MINIMISATION DE PRODUITS DE DEGRADATION DE LIGANDS OU REVERSION DE CES DERNIERS EN LIGANDS PHOSPHINE UTILES
  申请人：UNION CARBIDE CHEM PLASTIC

  公开号：WO2005007602A1

  公开（公告）日：2005-01-27

  A process for the minimization of phosphonium ion ligand degradation products formed during reaction of a polyunsaturated olefin or an unconjugated functionalized olefin in the presence of a transition metal-triorganophosphine ligand complex catalyst to form as a product, by-product, or intermediate product a conjugated functionalized olefin having a carbon-carbon double bond conjugated to an a-electron­withdrawing group, such as, an a,ß-unsaturated aldehyde, ketone, ester, acid, or nitrile. The minimization process involves conducting the reaction under selected conditions of conversion, temperature, pressure, or a combination thereof; and/or by selecting a triorganophosphine ligand with a specified steric and/or electronic property. Further, a process for reversion of phosphonium ion ligand degradation product(s) back to useful triorganophosphine ligand(s), the reversion involving treating a reaction product fluid containing the degradation product(s) with an inert gas, hydrogen, synthesis gas, or a mixture thereof under conditions sufficient to regenerate the triorganophosphine ligand(s).

  一种用于在存在过渡金属-三有机膦配体复合催化剂的情况下，通过反应多不饱和烯烃或非共轭官能化烯烃以形成产品、副产品或中间产物的方法，以最小化磷酮离子配体降解产物的过程，所述产物为具有碳-碳双键与α-电子受体基团共轭的官能化烯烃，如α,β-不饱和醛、酮、酯、酸或腈。最小化过程涉及在选择的转化率、温度、压力或其组合条件下进行反应；和/或通过选择具有特定立体和/或电子性能的三有机膦配体。此外，一种将磷酮离子配体降解产物回复为有用的三有机膦配体的方法，该回复涉及用惰性气体、氢气、合成气或二者的混合物处理含有降解产物的反应产物流体，在足以再生三有机膦配体的条件下进行处理。
• Minimization of ligand degradation products, or reversion of same to useful phosphine ligands
  申请人：Dow Technology Investments LLC

  公开号：EP2308817A2

  公开（公告）日：2011-04-13

  A process for the minimization of phosphonium ion ligand degradation products formed during reaction of polyunsaturated olefin or an unconjugated functionalized olefin in the presence of a transition metal-triorganophosphine ligand complex catalyst to form as a product, by-product, or intermediate product a conjugated functionalized olefin having a carbon-carbon double bond conjugated to an a-electronwithdrawing group, such as, an α,β-unsaturated aldehyde, ketone, ester, acid, or nitrile. The minimization process involves conducting the reaction under selected conditions of conversion, temperature, pressure, or a combination thereof; and/or by selecting a triorganophosphine ligand with a specified steric and/or electronic property. Further, a process for reversion of phosphonium ion ligand degradation product(s) back to useful triorganophosphine ligand(s), the reversion involving treating a reaction product fluid containing the degradation product(s) with an inert gas, hydrogen, synthesis gas, or a mixture thereof under conditions sufficient to regenerate the triorganophosphine ligand(s).

  一种将多不饱和烯烃或未共轭官能化烯烃在过渡金属-三有机膦配体络合物催化剂存在下反应过程中形成的膦离子配体降解产物降至最低以形成产物的工艺、副产物或中间产物共轭官能化烯烃，该烯烃具有与吸电子基团共轭的碳碳双键，如 α、β-不饱和醛、酮、酯、酸或腈。最小化过程包括在选定的转化条件、温度、压力或其组合条件下进行反应；和/或选择具有特定立体和/或电子特性的三有机膦配体。此外，一种将鏻离子配体降解产物还原为有用的三有机膦配体的工艺，还原过程包括在足以再生三有机膦配体的条件下，用惰性气体、氢气、合成气或其混合物处理含有降解产物的反应产物流体。
• MINIMIZATION OF LIGAND DEGRADATION PRODUCTS, OR REVERSION OF SAME TO USEFUL PHOSPHINE LIGANDS
  申请人：UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION

  公开号：EP1646599A1

  公开（公告）日：2006-04-19
• Minimization of ligand degradation products, of reversion of same to useful phosphine ligands
  申请人：Briggs R John

  公开号：US20070100169A1

  公开（公告）日：2007-05-03

  A process for the minimization of phosphonium ion ligand degradation products formed during reaction of a polyunsaturated olefin or an unconjugated functionalized olefin in the presence of a transition metal-triorganophosphine ligand complex catalyst to form as a product, by-product, or intermediate product a conjugated functionalized olefin having a carbon-carbon double bond conjugated to an αelectronwithdrawing group, such as, an α,β-unsaturated aldehyde, ketone, ester, acid, or nitrile. The minimization process involves conducting the reaction under selected conditions of conversion, temperature, pressure, or a combination thereof; and/or by selecting a triorganophosphine ligand with a specified steric and/or electronic property. Further, a process for reversion of phosphonium ion ligand degradation product(s) back to useful triorganophosphine ligand(s), the reversion involving treating a reaction product fluid containing the degradation product(s) with an inert gas, hydrogen, synthesis gas, or a mixture thereof under conditions sufficient to regenerate the triorganophosphine ligand(s).
• Method for Increasing the Content of Polyunsaturated Long-Chained Fatty Acids in Transgenic Organisms
  申请人：Cirpus Petra

  公开号：US20080076164A1

  公开（公告）日：2008-03-27

  The present invention relates to a method for increasing the content of polyunsaturated long-chain fatty acids in an organism by introducing into said organism nucleic acids coding for polypeptides or proteins exhibiting a phospholipase, ketoacyl-CoA reductase and/or dehydratase activity. Advantageously, said enzymes originate from Ostreococcus or Thraustochytrium. The present invention further relates to the nucleic acid sequences, nucleic acid constructs, vectors and organisms containing the nucleic acid sequences according to the present invention, vectors containing the nucleic acid sequences and/or the nucleic acid constructs as well as to transgenic organisms containing the above mentioned nucleic acid sequences, nucleic acid constructs and/or vectors. Advantageously, said previously mentioned nucleic acid sequences, nucleic acid constructs, vectors can optionally be expressed in the organism together with further nucleic acid sequences coding for polypeptides or proteins of the biosynthesis of the fatty acid or lipid metabolism. Particularly advantageous herein are those nucleic acid sequences of the fatty acid or lipid metabolism that code for a Δ-9 elongase, Δ-8 desaturase, Δ-6 desaturase, a Δ-5 desaturase, Δ-4 desaturase, Δ-12 desaturase, Δ-5 elongase and/or Δ-6 elongase activity. Advantageously, said desaturases and elongases originate from organisms like Thalassiosira, Euglena, Isochrysis, Physcomitrella, Thraustochytrium, Borago, Phytophthora, Crypthecodinium, Oncorhynchus, Primula, Xenopus, Ciona, Arabidopsis, Mortierella, Caenorhabditis, Phaeodactylum, Ceratodon or Ostreococcus. A further part of the present invention relates to oils, lipids and/or fatty acids produced according to the method of the present invention and the use thereof. Furthermore, the present invention relates to unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty acids and the use thereof.